| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_785ac2b35073f5a6d251678e6fb31b6f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-582 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 |
| filingDate |
2002-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0c269cc64aa7fdc82e1d7971db3d5d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c385ab578264c193bb7dd637eea8c1c4 |
| publicationDate |
2004-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004023383-A1 |
| titleOfInvention |
Antisense modulation of resistin expression |
| abstract |
Antisense compounds, compositions and methods are provided for modulating the expression of resistin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding resistin. Methods of using these compounds for modulation of resistin expression and for treatment of diseases associated with expression of resistin are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010105046-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012048414-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10920225-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017321217-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006099608-A1 |
| priorityDate |
2002-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |